Security key
15117K103
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)
CUSIP: 15117K103
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Ordinary Shares, nominal value EUR0.05 per share
- Shares outstanding
- 95,490,450
- Total 13F shares
- 5,703,192
- Share change
- +43,979
- Total reported value
- $136,879,000
- Put/Call ratio
- 463%
- Price per share
- $24.00
- Number of holders
- 39
- Value change
- +$1,857,397
- Number of buys
- 16
- Number of sells
- 15
Report period
Q1 2017
Institutions
39
Top holders
10
CLLS full security history
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Cellectis S.A. SEC filings
Cellectis S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117K103
Recent filing periods:
Top shareholders of CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.7%
|
3,530,406
|
$59,840,000 | — | 31 Dec 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.37%
|
350,000
|
$5,933,000 | — | 31 Dec 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.32%
|
310,250
|
$5,259,000 | — | 31 Dec 2016 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.31%
|
300,754
|
$5,097,000 | — | 31 Dec 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.26%
|
243,700
|
$4,131,000 | — | 31 Dec 2016 | |
| Artal Group S.A. |
13F
|
Company |
0.16%
|
150,000
|
$2,543,000 | — | 31 Dec 2016 | |
| Abingworth LLP |
13F
|
Company |
0.1%
|
100,000
|
$1,691,000 | — | 31 Dec 2016 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.1%
|
97,096
|
$1,646,000 | — | 31 Dec 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
70,703
|
$1,198,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
70,057
|
$1,188,000 | — | 31 Dec 2016 | |
| DSC Advisors, L.P. |
13F
|
Company |
0.06%
|
57,500
|
$975,000 | — | 31 Dec 2016 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
55,635
|
$943,000 | — | 31 Dec 2016 | |
| GAM Holding AG |
13F
|
Company |
0.06%
|
53,020
|
$899,000 | — | 31 Dec 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.05%
|
50,000
|
$848,000 | — | 31 Dec 2016 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
46,138
|
$782,000 | — | 31 Dec 2016 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.04%
|
42,498
|
$720,000 | — | 31 Dec 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
15,195
|
$258,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
14,707
|
$249,000 | — | 31 Dec 2016 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
0.02%
|
14,600
|
$247,000 | — | 31 Dec 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
13,026
|
$221,000 | — | 31 Dec 2016 | |
| ELLINGTON MANAGEMENT GROUP LLC |
13F
|
Company |
0.01%
|
12,400
|
$210,000 | — | 31 Dec 2016 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.01%
|
12,330
|
$210,000 | — | 31 Dec 2016 | |
| Fiera Capital Corp |
13F
|
Company |
0.01%
|
11,952
|
$203,000 | — | 31 Dec 2016 | |
| OLD MISSION CAPITAL, LLC |
13F
|
Company |
0.01%
|
10,956
|
$186,000 | — | 31 Dec 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,553
|
$179,000 | — | 31 Dec 2016 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.01%
|
10,010
|
$170,000 | — | 31 Dec 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
5,000
|
$85,000 | — | 31 Dec 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
4,913
|
$83,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
3,600
|
$61,000 | — | 31 Dec 2016 | |
| FNY Partners Fund LP |
13F
|
Company |
0%
|
1,000
|
$17,000 | — | 31 Dec 2016 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
900
|
$15,000 | — | 31 Dec 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
500
|
$8,000 | — | 31 Dec 2016 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
400
|
$7,000 | — | 31 Dec 2016 | |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
200
|
$3,000 | — | 31 Dec 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
170
|
$3,000 | — | 31 Dec 2016 | |
| TRENT CAPITAL MANAGEMENT INC /NC/ |
13F
|
Company |
0%
|
105
|
$2,000 | — | 31 Dec 2016 |
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2017
As of 31 Mar 2017,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,703,192 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, Tekla Capital Management LLC, LAZARD ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., Artal Group S.A., Abingworth LLP, venBio Select Advisor LLC, and DAFNA Capital Management LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
36
Q1 2017 holders
39
Holder diff
3
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.